Leukaemia
Evaluation of gene expression in circulating leukocytes in type 2 diabetes mellitus in western Uttar Pradesh
Who can joinAdults
Age35–60 years
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Government Institute of Medical Sciences (GIMS)DelhiDirections ↗
Registry summary (technical)
Evaluation of sirt1 and sirt4 gene expression in circulating leukocytes in type 2 diabetes mellitus in western Uttar Pradesh - NIL
Sponsor: Government Institute of Medical Sciences (GIMS)
CTRI/2025/10/096395 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 17 Nov 2025 · read by us 5 Nov 2026